s Údaje od 809 pacientů užívajících Nespo v evropských klinických studiích byly podrobeny analýze
er Data from 809 patients receiving Nespo in European clinical studies were analysed to assess the dose ng required to maintain haemoglobin; no difference was observed between the average weekly dose administered via the intravenous or subcutaneous routes of injection. lo